GTBIF (Green Thumb Industries) EBIT: $307 Mil (TTM As of Mar. 2026)


GTBIF Green Thumb Industries Inc GTBIF
85 GF Score
Price $7.47
GF Value $8.89
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Green Thumb Industries EBIT?

Green Thumb Industries GTBIF +1.08% 85 EBIT is $307 Mil as of Mar. 2026. GuruFocus rates GTBIF with a GF Score™ of 85/100 and a GF Value™ of $8.89 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Green Thumb Industries's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $68 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $307 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Green Thumb Industries's annualized ROC % for the quarter that ended in Mar. 2026 was 1.65%. Green Thumb Industries's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 26.40%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Green Thumb Industries's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.60%.

Green Thumb Industries  (OTCPK:GTBIF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Green Thumb Industries's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=162.936 * ( 1 - 76.17% )/( (2375.289 + 2335.498)/ 2 )
=38.8276488/2355.3935
=1.65 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2790.056 - 140.469 - ( 274.298 - max(0, 177.315 - 577.171+274.298))
=2375.289

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2831.606 - 151.596 - ( 344.512 - max(0, 194.155 - 673.85+344.512))
=2335.498

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Green Thumb Industries's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=273.216/( ( (930.555 + max(109.638, 0)) + (924.227 + max(105.742, 0)) )/ 2 )
=273.216/( ( 1040.193 + 1029.969 )/ 2 )
=273.216/1035.081
=26.40 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(51.269 + 158.288 + 40.55) - (140.469 + 0 + 0)
=109.638

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(51.897 + 170.034 + 35.407) - (151.596 + 0 + 0)
=105.742

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Green Thumb Industries's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=307.096/1849.785
=16.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Green Thumb Industries EBIT Related Terms

Green Thumb Industries EBIT Historical Data

* Premium members only.

The historical data trend for Green Thumb Industries's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Green Thumb Industries EBIT Chart

Green Thumb Industries Annual Data
Trend Feb16 Feb17 Feb18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 226.95 129.63 175.12 224.41 283.37

Green Thumb Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.58 27.35 78.15 133.29 68.30

GTBIF vs ZTS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Green Thumb Industries EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Green Thumb Industries's EV-to-EBIT falls into.


GTBIF
85GF Score
Green Thumb Industries Inc GTBIF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Green Thumb Industries EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $307 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $307 Mil mean?
Green Thumb Industries (GTBIF) has a EBIT of $307 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Green Thumb Industries.
Is Green Thumb Industries' EBIT too high?
Green Thumb Industries' current EBIT is $307 Mil. Overall, Green Thumb Industries has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Green Thumb Industries' EBIT compare to ZTS?
Green Thumb Industries' EBIT of $307 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Green Thumb Industries. Green Thumb Industries's current EBIT is $307 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Thumb Industries stock overvalued right now?
Based on GuruFocus' analysis, Green Thumb Industries (GTBIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.89, compared to a current price of $7.47 — trading 16% below its estimated fair value. The current EBIT is $307 Mil. Green Thumb Industries' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Green Thumb Industries (GTBIF), the current EBIT is $307 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Green Thumb Industries (GTBIF) Overvalued in 2026?

Based on GuruFocus' analysis, Green Thumb Industries stock appears to be undervalued. The current stock price of $7.47 is trading 16% below its estimated GF Value™ of $8.89. GuruFocus considers Green Thumb Industries to be Modestly Undervalued.

Key valuation signals for GTBIF:

  • EBIT: $307 Mil
  • GF Value™: $8.89 vs. price of $7.47 (16% below fair value)
  • GF Score™: 85/100 with 6 warning signs

No single metric tells the full story. See the GTBIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Green Thumb Industries Business Description

Other Exchanges R9U2:GermanyGTII:Canada
Address 325 West Huron Street, Suite 700, Chicago, IL, USA, 60654
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 100 cannabis stores under the brand Rise. GTI is focusing its expansion on limited-license states with large populations, and it does not currently export into the global medical market due to the USA federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, Incredibles, and RYTHM.
85GF Score

Get the complete analysis for GTBIF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.47
Price
$8.89
GF Value